The session will include a discussion of Asterias' CIRM-funded Phase 1/2a dose escalation clinical trial for SCI. In addition to Dr. Lebkowski, participants include , Ph.D., a CIRM science officer.
http://ift.tt/1xzD9xZ
http://ift.tt/1xzD9xZ
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment